Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer

J Chiche, MC Brahimi‐Horn… - Journal of cellular and …, 2010 - Wiley Online Library
Introduction• Intracellular pH regulation controls energy balance and cell proliferation:
chemical and biological proof of principle‐Chemical proof of principle‐Biological proof of …

[HTML][HTML] Cancer cells change their glucose metabolism to overcome increased ROS: One step from cancer cell to cancer stem cell?

ZG Movahed, M Rastegari-Pouyani… - Biomedicine & …, 2019 - Elsevier
Cancer cells can adapt to low energy sources in the face of ATP depletion as well as to their
high levels of ROS by altering their metabolism and energy production networks which might …

[HTML][HTML] Recent developments in targeting carbonic anhydrase IX for cancer therapeutics

PC McDonald, JY Winum, CT Supuran, S Dedhar - Oncotarget, 2012 - ncbi.nlm.nih.gov
Carbonic anhydrase IX (CAIX) is a hypoxia-inducible enzyme that is overexpressed by
cancer cells from many tumor types, and is a component of the pH regulatory system …

Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology

G Sutendra, ED Michelakis - Frontiers in oncology, 2013 - frontiersin.org
Current drug development in oncology is non-selective as it typically focuses on pathways
essential for the survival of all dividing cells. The unique metabolic profile of cancer, which is …

Reciprocal influence of the p53 and the hypoxic pathways

A Sermeus, C Michiels - Cell death & disease, 2011 - nature.com
When cells sense a decrease in oxygen availability (hypoxia), they develop adaptive
responses in order to sustain this condition and survive. If hypoxia lasts too long or is too …

A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in …

G Sutendra, P Dromparis, R Paulin… - Journal of molecular …, 2013 - Springer
Right ventricular (RV) failure is an important clinical problem with no available therapies,
largely because its molecular mechanisms are unknown. Mitochondrial remodeling resulting …

Mitochondria in vascular health and disease

P Dromparis, ED Michelakis - Annual review of physiology, 2013 - annualreviews.org
The eukaryote's mitochondrial network is perhaps the cell's most sophisticated and dynamic
responsive sensing system. Integrating metabolic, oxygen, or danger signals with inputs …

Negative and positive regulation of HIF-1: a complex network

JI Bárdos, M Ashcroft - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2005 - Elsevier
Hypoxia inducible factor-1 (HIF-1) is as a key transcriptional mediator of the hypoxic
response in eukaryotic cells, regulating the expression of a myriad of genes involved in …

Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome

JG Teodoro, SK Evans, MR Green - Journal of molecular medicine, 2007 - Springer
The p53 tumor suppressor protein has long been recognized as the central factor protecting
humans from cancer. It has been famously dubbed “the guardian of the genome” due to its …

Melanoma: from melanocyte to genetic alterations and clinical options

C Bertolotto - Scientifica, 2013 - Wiley Online Library
Metastatic melanoma remained for decades without any effective treatment and was thus
considered as a paradigm of cancer resistance. Recent progress with understanding of the …